|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/443 | (2006.01) |
| A61K 31/405 | (2006.01) | ||
| A61K 31/4164 | (2006.01) | ||
| A61K 31/4245 | (2006.01) | ||
| A61K 31/43 | (2006.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/4965 | (2006.01) | ||
| A61K 31/7036 | (2006.01) | ||
| A61K 31/734 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 3273995 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16711320.8 |
| Date of filing the European patent application | 2016-03-23 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/056458 |
| Date | 2016-03-23 |
| (87) | Number | WO 2016/151051 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 201504878 | 2015-03-23 | GB |
| (72) |
DESSEN, Arne , NO
MYRSET, Astrid Hilde , NO
RYE, Philip , NO
|
| (73) |
ALGIPHARMA AS ,
Industriveien 33, 1337 Sandvika,
NO
|
| (54) | COMBINED USE OF ALGINATE OLIGOMERS AND THE CFTR MODULATOR LUMACAFTOR IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH CFTR DYSFUNCTION |
| COMBINED USE OF ALGINATE OLIGOMERS AND THE CFTR MODULATOR LUMACAFTOR IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH CFTR DYSFUNCTION |